Alimera Sciences Company Profile (NASDAQ:ALIM)

About Alimera Sciences

Alimera Sciences logoAlimera Sciences, Inc. (Alimera) is a pharmaceutical company. The Company is engaged in the research, development and commercialization of prescription ophthalmic pharmaceuticals. The Company operates through two segments: U.S. and International. The Company focuses on diseases affecting the back of the eye or retina. The Company's product is ILUVIEN, which is developed to treat diabetic macular edema (DME). DME is a disease of the retina that affects individuals with diabetes and can lead to severe vision loss and blindness. In the United States, ILUVIEN is indicated for the treatment of DME in patients who have been treated with a course of corticosteroids and did not have a rise in intraocular pressure (IOP). In the European Economic Area (EEA) countries, ILUVIEN is indicated for the treatment of vision impairment associated with DME considered insufficiently responsive to available therapies.

Industry, Sector and Symbol:
  • Sector: Medical
  • Industry: Drug Manufacturers - Major
  • Sub-Industry: N/A
  • Exchange: NASDAQ
  • Symbol: ALIM
  • CUSIP:
Key Metrics:
  • Previous Close: $1.56
  • 50 Day Moving Average: $1.57
  • 200 Day Moving Average: $1.74
  • 52-Week Range: $1.01 - $5.15
  • Trailing P/E Ratio: N/A
  • Foreward P/E Ratio: -8.50
  • P/E Growth: 0.00
  • Market Cap: $70.93M
  • Outstanding Shares: 45,759,000
  • Beta: 2.25
Additional Links:
Companies Related to Alimera Sciences:

Analyst Ratings

Consensus Ratings for Alimera Sciences (NASDAQ:ALIM) (?)
Ratings Breakdown: 1 Hold Rating, 1 Buy Rating
Consensus Rating:Buy (Score: 2.50)
Consensus Price Target: $3.67 (139.65% upside)

Analysts' Ratings History for Alimera Sciences (NASDAQ:ALIM)
Show:
DateFirmActionRatingPrice TargetDetails
8/5/2016Cowen and CompanyReiterated RatingMarket Perform$2.00View Rating Details
3/4/2016Cantor FitzgeraldLower Price TargetBuy$6.00 -> $5.00View Rating Details
11/26/2015Credit Suisse Group AGLower Price Target$5.00 -> $4.00View Rating Details
11/17/2014Summer StreetInitiated CoverageBuy -> Buy$12.00View Rating Details
9/29/2014Northland SecuritiesBoost Price TargetOutperform$7.00 -> $10.00View Rating Details
(Data available from 8/31/2014 forward)

Earnings

Earnings History for Alimera Sciences (NASDAQ:ALIM)
DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallDetails
11/3/2016        
8/3/2016Q2($0.19)($0.17)$8.42 million$3.80 millionViewN/AView Earnings Details
5/4/2016Q1($0.19)($0.22)$5.83 million$5.80 millionViewN/AView Earnings Details
11/5/2015Q315($0.21)($0.21)$6.96 million$6.90 millionViewN/AView Earnings Details
8/10/2015Q215($0.22)($0.25)$6.49 million$5.80 millionViewListenView Earnings Details
5/7/2015Q115($0.24)($0.27)$3.90 million$3.90 millionViewN/AView Earnings Details
3/4/2015Q414$0.17($0.28)$5.11 million$1.70 millionViewN/AView Earnings Details
11/6/2014Q314($0.70)($0.22)$3.75 million$2.40 millionViewN/AView Earnings Details
8/7/2014Q214($0.23)($0.15)$2.70 million$2.19 millionViewN/AView Earnings Details
5/8/2014Q114($0.25)($0.20)$1.15 million$2.08 millionViewN/AView Earnings Details
2/27/2014Q413($0.29)($0.24)$0.75 million$0.94 millionViewN/AView Earnings Details
11/11/2013Q313($0.30)($0.26)$0.38 million$0.76 millionViewN/AView Earnings Details
8/12/2013Q2 2013($0.24)($0.30)$3.00 millionViewN/AView Earnings Details
5/9/2013Q1 2013($0.26)($0.27)ViewN/AView Earnings Details
3/21/2013Q4 2012($0.23)($0.17)ViewN/AView Earnings Details
11/7/2012Q312($0.19)($0.17)ViewN/AView Earnings Details
3/8/2012($0.24)($0.19)ViewN/AView Earnings Details
11/3/2011($0.19)($0.21)ViewN/AView Earnings Details
8/4/2011($0.18)($0.17)ViewN/AView Earnings Details
5/5/2011($0.20)($0.15)ViewN/AView Earnings Details
2/10/2011($0.22)($0.20)ViewN/AView Earnings Details
(Data available from 1/1/2011 forward)

Estimates

Earnings Estimates for Alimera Sciences (NASDAQ:ALIM)
Current Year EPS Consensus Estimate: $-0.54 EPS
Next Year EPS Consensus Estimate: $-0.18 EPS

Dividends

Dividend History for Alimera Sciences (NASDAQ:ALIM)
No dividend announcements for this company have been tracked by MarketBeat.com

Insider Trades

Insider Trading History for Alimera Sciences (NASDAQ:ALIM)
Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails
4/21/2016L.P. BavpMajor ShareholderSell478,673$2.59$1,239,763.07View SEC Filing  
12/16/2015Richard S. Eiswirth, Jr.CFOSell46,669$2.31$107,805.39View SEC Filing  
12/8/2015James E FlynnInsiderBuy272,249$3.01$819,469.49View SEC Filing  
12/3/2015James E FlynnInsiderBuy243,252$3.00$729,756.00View SEC Filing  
10/30/2015James E FlynnInsiderBuy16,542$3.00$49,626.00View SEC Filing  
10/28/2015James E FlynnInsiderBuy59,342$3.00$178,026.00View SEC Filing  
10/26/2015James E FlynnInsiderBuy60,364$3.00$181,092.00View SEC Filing  
10/21/2015James E FlynnMajor ShareholderBuy160,684$3.00$482,052.00View SEC Filing  
10/20/2015James E FlynnMajor ShareholderBuy100,130$3.00$300,390.00View SEC Filing  
10/19/2015James E FlynnMajor ShareholderBuy129,226$2.92$377,339.92View SEC Filing  
10/15/2015Richard S. Eiswirth, Jr.CFOSell13,625$2.69$36,651.25View SEC Filing  
10/9/2015James E FlynnInsiderBuy321,785$2.42$778,719.70View SEC Filing  
9/3/2015Calvin W RobertsDirectorBuy6,424$3.00$19,272.00View SEC Filing  
8/21/2015Kenneth GreenSVPSell20,000$3.29$65,800.00View SEC Filing  
8/17/2015Kenneth GreenSVPSell20,000$3.90$78,000.00View SEC Filing  
6/26/2015L.P. BavpMajor ShareholderSell1,024$5.00$5,120.00View SEC Filing  
6/19/2015L.P. BavpMajor ShareholderSell5,568$5.00$27,840.00View SEC Filing  
5/1/2015C. Daniel MyersCEOSell2,000$4.37$8,740.00View SEC Filing  
4/27/2015L.P. BavpMajor ShareholderSell3,114$5.02$15,632.28View SEC Filing  
4/23/2015L.P. BavpMajor ShareholderSell4,362$5.00$21,810.00View SEC Filing  
4/20/2015L.P. BavpMajor ShareholderSell30,300$5.03$152,409.00View SEC Filing  
4/15/2015L.P. BavpMajor ShareholderSell35,800$5.03$180,074.00View SEC Filing  
4/14/2015L.P. BavpMajor ShareholderSell18,400$5.01$92,184.00View SEC Filing  
4/13/2015L.P. BavpMajor ShareholderSell100$5.00$500.00View SEC Filing  
3/6/2015Richard S Eiswirth JrCFOBuy10,000$4.84$48,400.00View SEC Filing  
3/2/2015C. Daniel MyersCEOSell2,000$5.21$10,420.00View SEC Filing  
1/2/2015C. Daniel MyersCEOSell2,000$5.51$11,020.00View SEC Filing  
1/2/2015David HollandSVPSell5,000$5.56$27,800.00View SEC Filing  
12/1/2014C. Daniel MyersCEOSell2,000$5.99$11,980.00View SEC Filing  
12/1/2014David HollandSVPSell5,000$5.71$28,550.00View SEC Filing  
10/27/2014L.P. BavpMajor ShareholderSell57,918$6.34$367,200.12View SEC Filing  
10/1/2014C. Daniel MyersCEOSell2,000$5.42$10,840.00View SEC Filing  
10/1/2014David HollandSVPSell5,000$5.26$26,300.00View SEC Filing  
10/1/2014Patrick LeeMajor ShareholderSell621,191$5.42$3,366,855.22View SEC Filing  
9/30/2014Patrick LeeMajor ShareholderSell354,062$5.42$1,919,016.04View SEC Filing  
9/29/2014Patrick LeeMajor ShareholderSell240,662$5.47$1,316,421.14View SEC Filing  
9/11/2014L.P. BavpMajor ShareholderSell2,816$6.25$17,600.00View SEC Filing  
9/4/2014L.P. BavpMajor ShareholderSell39,500$6.33$250,035.00View SEC Filing  
8/29/2014L.P. BavpMajor ShareholderSell7,400$6.27$46,398.00View SEC Filing  
8/28/2014L.P. BavpMajor ShareholderSell3,000$6.27$18,810.00View SEC Filing  
8/1/2014David HollandSVPSell5,000$5.64$28,200.00View SEC Filing  
7/1/2014David HollandSVPSell5,000$6.02$30,100.00View SEC Filing  
5/1/2014David HollandSVPSell5,000$5.93$29,650.00View SEC Filing  
3/4/2014C. Daniel MyersCEOSell22,775$7.10$161,702.50View SEC Filing  
3/4/2014David HollandSVPSell10,000$6.84$68,400.00View SEC Filing  
3/4/2014Susan CaballaInsiderSell8,931$7.01$62,606.31View SEC Filing  
1/16/2014Domain Partners Vi, L.P.Major ShareholderSell296,760$6.39$1,896,296.40View SEC Filing  
7/17/2013Polaris Venture Management CoInsiderSell122,937$4.80$590,097.60View SEC Filing  
6/20/2013Domain Partners Vi, L.P.Major ShareholderSell10,516$5.01$52,685.16View SEC Filing  
6/19/2013Domain Partners Vi, L.P.Major ShareholderSell55,278$5.39$297,948.42View SEC Filing  
6/18/2013Polaris Venture Management CoInsiderSell37,063$5.44$201,622.72View SEC Filing  
6/17/2013Domain Partners Vi, L.P.Major ShareholderSell126,709$5.29$670,290.61View SEC Filing  
6/11/2013Domain Partners Vi, L.P.Major ShareholderSell5,337$5.00$26,685.00View SEC Filing  
5/17/2013David HollandSVPSell30,000$4.13$123,900.00View SEC Filing  
5/16/2013Domain Partners Vi, L.P.Major ShareholderSell44,242$4.60$203,513.20View SEC Filing  
12/13/2012Peter J Pizzo IIIDirectorBuy5,000$1.44$7,200.00View SEC Filing  
12/3/2012C. Daniel MyersCEOSell7,700$1.95$15,015.00View SEC Filing  
(Data available from 1/1/2013 forward)

Headlines

Latest Headlines for Alimera Sciences (NASDAQ:ALIM)
DateHeadline
seekingalpha.com logoAlimera: Reassessing The Thesis After The Equity Raise - Seeking Alpha (NASDAQ:ALIM)
seekingalpha.com - August 25 at 3:28 PM
reuters.com logoBRIEF-Crown castle announces pricing of senior notes offering (NASDAQ:ALIM)
uk.reuters.com - August 23 at 8:43 PM
insidermonkey.com logoAlimera Sciences Inc (ALIM): Great Point Partners Reveals 5.12% Stake - Insider Monkey (blog) (NASDAQ:ALIM)
www.insidermonkey.com - August 23 at 3:26 PM
News IconAlimera Sciences Inc (ALIM): Great Point Partners Reveals 5.12% Stake (NASDAQ:ALIM)
feedproxy.google.com - August 23 at 9:41 AM
reuters.com logoBRIEF-Great point reports 5.12 pct passive stake in Alimera Sciences - SEC... - Reuters (NASDAQ:ALIM)
www.reuters.com - August 22 at 8:35 PM
News IconAlimera Sciences, Inc. (NASDAQ:ALIM) Near to Lift Curtain on September 2016 Earnings - The Voice Registrar (NASDAQ:ALIM)
voiceregistrar.com - August 17 at 8:55 PM
globenewswire.com logoAlimera Sciences Announces Exercise of Underwriters' Over-Allotment Option and Closing of $26.5 Million Offering of ... - GlobeNewswire (press release) (NASDAQ:ALIM)
globenewswire.com - August 17 at 11:39 AM
live-pr.com logoNew Study: Alimera Sciences, Inc. (ALIM) - Financial and Strategic SWOT Analysis Review (NASDAQ:ALIM)
www.live-pr.com - August 16 at 8:44 PM
finance.yahoo.com logoAlimera Sciences Announces Exercise of Underwriters’ Over-Allotment Option and Closing of $26.5 Million Offering of Common Stock (NASDAQ:ALIM)
finance.yahoo.com - August 16 at 8:44 PM
publicnow.com logoAlimera Sciences Announces Exercise of Underwriters' Over-Allotment Option and Closing of $26.5 Million Offering of Common Stock (NASDAQ:ALIM)
www.publicnow.com - August 16 at 8:44 PM
News IconStocks Under Consideration: Alimera Sciences Inc (NASDAQ:ALIM), HP Inc (NYSE:HPQ) - NYSE Journal (press release) (NASDAQ:ALIM)
stockznews.com - August 15 at 3:28 PM
finance.yahoo.com logoALIMERA SCIENCES INC Financials (NASDAQ:ALIM)
finance.yahoo.com - August 13 at 3:24 PM
News IconNewell Brands Inc (NYSE:NWL) & Alimera Sciences (NASDAQ:ALIM) Stocks in the News - Money News (press release) (NASDAQ:ALIM)
www.newsismoney.com - August 12 at 3:34 PM
capitalcube.com logoETF’s with exposure to Alimera Sciences, Inc. : August 12, 2016 (NASDAQ:ALIM)
www.capitalcube.com - August 12 at 3:34 PM
streetinsider.com logoAlimera Sciences (ALIM) Prices 18M Common Stock Offering at $1.40/Share (NASDAQ:ALIM)
www.streetinsider.com - August 12 at 12:00 PM
globenewswire.com logoAlimera Sciences Prices Public Offering of Common Stock - GlobeNewswire (press release) (NASDAQ:ALIM)
globenewswire.com - August 11 at 9:17 PM
finance.yahoo.com logoAlimera Sciences Prices Public Offering of Common Stock - Yahoo Finance (NASDAQ:ALIM)
finance.yahoo.com - August 11 at 3:28 PM
finance.yahoo.com logoAlimera Sciences Proposes Public Offering of Common Stock - Yahoo Finance (NASDAQ:ALIM)
finance.yahoo.com - August 11 at 12:40 PM
finance.yahoo.com logo8:42 am Alimera Sciences prices an 18 mln share underwritten public offering of common stock at $1.40/share for gross proceeds of ~$25.2 mln (NASDAQ:ALIM)
finance.yahoo.com - August 11 at 12:40 PM
biz.yahoo.com logoALIMERA SCIENCES INC Files SEC form 8-K, Entry into a Material Definitive Agreement, Other Events (NASDAQ:ALIM)
biz.yahoo.com - August 11 at 12:40 PM
publicnow.com logoAlimera Sciences Prices Public Offering of Common Stock (NASDAQ:ALIM)
www.publicnow.com - August 11 at 12:40 PM
capitalcube.com logoAlimera Sciences, Inc. :ALIM-US: Earnings Analysis: Q2, 2016 By the Numbers : August 11, 2016 (NASDAQ:ALIM)
www.capitalcube.com - August 11 at 12:40 PM
streetinsider.com logoAfter-Hours Stock Movers 08/10: (KURA) (ANW) (CHK) Higher; (AVGR) (OMER) (SHAK) Lower (more...) (NASDAQ:ALIM)
www.streetinsider.com - August 10 at 9:53 PM
biz.yahoo.com logoALIMERA SCIENCES INC Files SEC form 8-K, Other Events (NASDAQ:ALIM)
biz.yahoo.com - August 10 at 9:53 PM
publicnow.com logoAlimera Sciences Proposes Public Offering of Common Stock (NASDAQ:ALIM)
www.publicnow.com - August 10 at 9:53 PM
News IconVigorous Movers' Roundup- American Airlines (NASDAQ:AAL), Alimera Sciences (NASDAQ:ALIM), Medivation ... - Seneca Globe (NASDAQ:ALIM)
www.senecaglobe.com - August 10 at 3:47 PM
nasdaq.com logoAlimera Sciences announces clinical presentations and sponsored Symposia at ASRS 2016 Annual meeting - Nasdaq (NASDAQ:ALIM)
www.nasdaq.com - August 9 at 4:31 PM
publicnow.com logoAlimera Sciences announces clinical presentations and sponsored Symposia at ASRS 2016 Annual meeting (NASDAQ:ALIM)
www.publicnow.com - August 9 at 12:11 PM
equities.com logoAlimera Sciences Inc. (ALIM) Drops 12% on August 04 - Equities.com (NASDAQ:ALIM)
www.equities.com - August 6 at 11:10 AM
biz.yahoo.com logoALIMERA SCIENCES INC Files SEC form 10-Q, Quarterly Report (NASDAQ:ALIM)
biz.yahoo.com - August 5 at 8:49 PM
finance.yahoo.com logoEdited Transcript of ALIM earnings conference call or presentation 4-Aug-16 2:00pm GMT (NASDAQ:ALIM)
finance.yahoo.com - August 5 at 8:49 PM
News IconPrice Target by Analysts: VEREIT, Inc. (NYSE:VER), Alimera Sciences, Inc. (NASDAQ:ALIM) - News Oracle (NASDAQ:ALIM)
www.newsoracle.com - August 5 at 3:26 PM
streetupdates.com logoStocks inside Analysts Spotlight: Alimera Sciences, Inc. (NASDAQ:ALIM) , Merrimack Pharmaceuticals, Inc. (NASDAQ ... - Street Updates (NASDAQ:ALIM)
www.streetupdates.com - August 5 at 3:26 PM
smarteranalyst.com logoCowen Remains Cautious on Alimera Sciences Inc (ALIM) Following 2Q:16 Results - Smarter Analyst (NASDAQ:ALIM)
www.smarteranalyst.com - August 5 at 11:50 AM
baystreet.ca logoAlimera Sciences (ALIM) Plummets on Q2 Loss (NASDAQ:ALIM)
www.baystreet.ca - August 4 at 9:09 PM
reuters.com logoBRIEF-Alimera Sciences Q2 GAAP loss per share $0.15 (NASDAQ:ALIM)
www.reuters.com - August 4 at 9:09 PM
twst.com logoAlimera Sciences Inc.: Alimera Sciences Announces Second Quarter 2016 Financial Results and Provides Business Update (NASDAQ:ALIM)
www.twst.com - August 4 at 9:09 PM
sg.finance.yahoo.com logoAlimera Sciences reports 2Q loss (NASDAQ:ALIM)
sg.finance.yahoo.com - August 4 at 11:56 AM
twst.com logoAlimera Sciences Inc.: Alimera Sciences Announces Second Quarter 2016 Financial Results and Provides Business ... - The Wall Street Transcript (NASDAQ:ALIM)
www.twst.com - August 3 at 9:04 PM
publicnow.com logoAlimera Sciences Announces Second Quarter 2016 Financial Results and Provides Business Update (NASDAQ:ALIM)
www.publicnow.com - August 3 at 9:04 PM
biz.yahoo.com logoQ2 2016 Alimera Sciences Inc Earnings Release - After Market Close (NASDAQ:ALIM)
biz.yahoo.com - August 3 at 11:59 AM
streetupdates.com logoAnalysts Update on Stocks: ARIAD Pharmaceuticals, Inc. (NASDAQ:ARIA) , Alimera Sciences, Inc. (NASDAQ:ALIM) - Street Updates (NASDAQ:ALIM)
www.streetupdates.com - August 2 at 8:10 AM
fortune.com logoNotable Research Reports: Alimera Sciences Inc (NASDAQ:ALIM), Bonanza Creek Energy Inc (NYSE:BCEI) - Review Fortune (NASDAQ:ALIM)
reviewfortune.com - August 1 at 3:23 PM
istreetwire.com logoStocks To Track: Summit Materials, Inc. (SUM), Alimera Sciences, Inc. (ALIM), Viacom, Inc. (VIAB) - iStreetWire (NASDAQ:ALIM)
istreetwire.com - August 1 at 8:13 AM
tradecalls.org logoAlimera Sciences (ALIM) Shares are Up 93.4% - Trade Calls (NASDAQ:ALIM)
www.tradecalls.org - August 1 at 8:13 AM
streetupdates.com logoMost recent Analysts Rating report: ARIAD Pharmaceuticals, Inc. (NASDAQ:ARIA) , Alimera Sciences, Inc. (NASDAQ ... - Street Updates (NASDAQ:ALIM)
www.streetupdates.com - August 1 at 8:13 AM
fortune.com logoNoteworthy Analysts Appraisal of 2 Stocks: Ariad Pharmaceuticals, Inc. (NASDAQ:ARIA), Alimera Sciences Inc ... - Review Fortune (NASDAQ:ALIM)
reviewfortune.com - July 29 at 3:26 PM
fortune.com logoAlimera Sciences, Inc. (NASDAQ:ALIM) Stock Rises, Analysts: Hold Rating - Review Fortune (NASDAQ:ALIM)
reviewfortune.com - July 29 at 3:26 PM
News IconThe Wonder Woman Trailer Will Make You Want Your Own Lasso (NASDAQ:ALIM)
bolsafinanzas.com - July 28 at 10:04 PM
seekingalpha.com logoAlimera: Risks Reduced After Q2 Pre-Announcement - Seeking Alpha (NASDAQ:ALIM)
seekingalpha.com - July 28 at 4:27 PM

Social

Alimera Sciences (NASDAQ:ALIM) Chart for Wednesday, August, 31, 2016


Last Updated on 8/31/2016 by MarketBeat.com Staff